The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases

Receptor activator of NF-kB (RANK) pathway regulates bone remodeling and is involved in breast cancer (BC) progression. Genetic polymorphisms affecting RANK-ligand (RANKL) and osteoprotegerin (OPG) have been previously associated with BC risk and bone metastasis (BM)-free survival, respectively. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Arlindo, Alho, Irina, Vendrell, Inês, Melo, Marta, Brás, Raquel, Costa, Ana Lúcia, Sousa, Ana Rita, Mansinho, André, Abreu, Catarina, Pulido, Catarina, Macedo, Daniela, Pacheco, Teresa, Correia, Lurdes, Costa, Luis, Casimiro, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173066/
https://www.ncbi.nlm.nih.gov/pubmed/27191503
http://dx.doi.org/10.18632/oncotarget.9356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173066/
https://www.ncbi.nlm.nih.gov/pubmed/27191503
http://dx.doi.org/10.18632/oncotarget.9356

Ejemplares similares